Updated: Recursion to acquire Exscientia to bolster pipeline in one of AI bio’s biggest M&A deals
Recursion and Exscientia, two longtime bellwethers of AI bio, agreed to merge in an all-stock deal valued at an estimated …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
